Key Takeaways

The Tobacco Master Settlement Agreement (MSA) Model

Parties Involved: Major tobacco companies versus 46 US states, the District of Columbia, and several territories.

States' Claim: States sued due to the negative externality of cigarettes causing cancer, which drove up medical bills in state healthcare systems.

Agreement Terms: States agreed to end major lawsuits against the tobacco companies. In return, companies would make large annual payments (totaling $206 billion initially, continuing indefinitely) and follow new limits on advertising and business practices, especially marketing to children.

Payment Structure: Annual payments change based on cigarette sales, inflation, market share, and other adjustments. Tobacco companies pay a share of the total based on their market share among MSA participants. Money is divided among states using fixed allocation percentages.

Financialization Aspect: States could 'financialize' these indefinite revenue streams by selling future payments to investment firms for a lump sum of cash, which they could then use for infrastructure projects or other needs.

When This Works (and When It Doesn't)

The Tobacco Master Settlement Agreement (MSA) Model springs into action when a product’s widespread economic harm translates directly into public health externalities that strain state budgets. As the podcast notes, this was the case with cigarettes, where the direct link between smoking and healthcare costs spurred states to demand long-term financial and regulatory solutions beyond individual litigation. This model is most effective when the product's negative impact is quantifiable, broadly distributed, and affects a significant portion of the population, leading to a strong public health claim.

However, this framework won't apply to every product with some downsides. It breaks down when the harm is diffuse, difficult to quantify, or primarily affects individuals rather than creating a systemic burden on state resources. Niche products, or those where the link between product use and public health cost is tenuous, won’t trigger this level of state-driven legal action. For founders, this means recognizing that the scale and nature of your product’s potential negative externalities are critical; minor individual complaints won't lead to a multi-billion dollar, indefinite payment structure.

What to Do With This

If you're building a widely adopted consumer product, especially one with features designed to maximize engagement or growth, you need to apply The Tobacco Master Settlement Agreement (MSA) Model to your own roadmap this week. Don't wait for the lawsuits. Ask: what negative externalities could our product create at scale, particularly for vulnerable user segments? John Coogan highlighted how the tobacco settlement created a system of “annual payments that continue indefinitely.” Track not just user growth and retention, but also proxy metrics for "addiction" or "harm"—think compulsive usage patterns or user-reported mental health impact. Proactively design in "friction" or "off-ramps" where appropriate, not because it’s "nice," but because anticipating and mitigating these systemic public health risks now could save your business from multi-billion dollar, indefinite payments and crippling regulatory restrictions down the line.